Neurological manifestations in patients with Gaucher disease and in their relatives;Manifestaciones neurológicas en pacientes con enfermedad de Gaucher y en sus familiares

Medicina Clinica

Volumn 131, Issue 5, 2008, Pages 175-179

  Giraldo, Pilar ^a,b,c,d   Capablo, José Luis ^a,c   Alfonso, Pilar ^a,c,d   Latre, Paz ^b,c   García, Beatriz ^a   Pocoví, Miguel ^b,c,d,e  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c Fundación Para el Estudio y la Terapéutica de la Enfermedad de Gaucher y Otras Lisosomales FEETEG   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^e UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Carriers; Gaucher disease; Neurological manifestations; Parkinson disease

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONCENTRATION LOSS; COORDINATION DISORDER; EPILEPSY; FAMILY STUDY; FEMALE; GAUCHER DISEASE; GENE MUTATION; HEARING IMPAIRMENT; HETEROZYGOTE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; RELATIVE; SCHOOL CHILD; STRABISMUS; TREMOR;

EID: 47649084452     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13124962     Document Type: Article

References (20)

1. Beutler E, Grabowski GA. Gaucher disease. En: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001. p. 3635-68.
2. Sidransky E. Gaucher disease: complexity in a «simple» disorder. Mol Genet Metab. 2004;83:6-15.
3. Pastores GM, Weinreb NJ, Aerts H, Andria G, Cox TM, Giralt M, et al. Therapeutic goals in the treatment of Gaucher disease. Semin Hematol. 2004;41 4 Suppl 5:4-14.
4. Pastores GM, Barnett NL, Bathan P, Kolodny EH. A neurological symptom survey of patients with type I Gaucher disease. J Inherit Metab Dis. 2003;26:641-5.
5. Capablo JL, Sáenz de Cabezón A, Fraile J, Alfonso P, Pocoví M, Giraldo P. Neurological evaluation of Gaucher disease patients with Gaucher disease diagnosed as type 1. J Neurol Neurosurg Psychiatry. 2008;79:219-22.
6. Tayebi N, Walker J, Stubblefield B, Orvisky E, LaMarca ME, Wong K, et al. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab. 2003;79:104-9.
7. Sánchez C. Impacto sociosanitario de las enfermedades neurológicas en España. Fundación Española de Enfermedades Neurológicas (FEEN) [consultado 28/08/07]: Disponible en: http://www.feeneurologia.com
8. Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Parkinsonism among Gaucher disease carriers. J Med Genet. 2004;41:937-40.
9. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med. 2004;351:1972-7.
10. Ziegler SG, Eblan MJ, Gutti U, Hruska KS, Stubblefield BK, Goker-Alpan O, et al. Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab. 2007;91:195-200.
11. Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, et al. Mutations in the glucocerebrosidase gene are associated with early onset Parkinson disease. Neurology. 2007;69: 1270-7.
12. Halperin A, Elstein D, Zimran A. Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease? Acta Neurol Scand. 2007;115:275-8.
13. Giraldo P, Pérez-Calvo JI, Giralt M, Pocoví M. Características clínicas de la enfermedad de Gaucher en España. Resultados preliminares de una encuesta nacional. Med Clin (Barc). 1997; 109: 619-22.
14. Halperin A, Elstein D, Zimran A. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. Blood Cells Mol Dis. 2006;36:426-8.
15. Kono S, Shirakawa K, Ouchi Y, Sakamoto M, Ida H, Sugiura T, et al. Dopaminergic neuronal dysfunction associated with parkinsonism in both a Gaucher disease patient and a carrier. J Neurol Sci. 2007;252:181-4.
16. Alfonso P, Aznárez S, Giralt M, Pocoví M, Giraldo P; Spanish Gaucher's Disease Registry. Mutation analysis and genotype/phenotype relationships of Gaucher disease patients in Spain. J Hum Gen. 2007;52:391-6.
17. Lacerda L, Amaral O, Pinto R, Oliveira P, Aerts J, Sa Miranda MC. Gaucher disease: N370S glucocerebrosidase gene frecuency in the Portuguesse population. Clin Genet. 1994;45:298-300.
18. Kowarz L, Goker-Alpan O, Banerjee-Basu S, LaMarca ME, Kinlaw L, Schiffmann R, et al. Gaucher mutation N188S is associated with myoclonic epilepsy. Hum Mutat. 2005;26:271-3.
19. Alfonso P, Cenarro A, Pérez-Calvo JI, Puzo J, Giralt M, Giraldo P, et al. Efecto del tratamiento enzimático sustitutivo sobre el perfil lipídico en pacientes con enfermedad de Gaucher. Med Clin (Barc). 2003;120:641-6.
20. Desnik RJ, Ioannou YA, Eng CM. Alpha-galactosidase A deficiency: Fabry disease. En: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: Mac Graw Hill; 1995. p. 2741-84.